Company Filing History:
Years Active: 2025
Title: Marco Groot - Innovator in Vaccine Emulsification
Introduction
Marco Groot is a notable inventor based in Beugen, Netherlands. He has made significant contributions to the field of vaccine formulation through his innovative work on stable emulsions of bacterial antigens. His research focuses on enhancing the stability and effectiveness of vaccines, which is crucial for public health.
Latest Patents
Marco Groot holds a patent for "Stable emulsions of bacterial antigens." This invention is based on the discovery of new and advantageous properties of a class of known polymeric emulsifiers. The emulsifier class was found to be resistant to degradation by crude bacterial antigen preparations, which caused emulsion instability when using prior art emulsifiers. This advancement allows for the formulation of safe, stable, and effective vaccines based on these emulsions of oil and water comprising such bacterial antigens. The polymeric emulsifier is a block copolymer with a general formula A-B-A, where component B is the divalent residue of a water-soluble polyalkylene glycol, and component A is the residue of an oil-soluble complex monocarboxylic acid. The preferred emulsifier is a PEG-30-di-(polyhydroxystearate).
Career Highlights
Marco Groot is associated with Intervet Inc., where he applies his expertise in vaccine development. His work has been instrumental in advancing the field of immunology and vaccine technology. With a focus on creating stable emulsions, he has contributed to the development of more effective vaccines.
Collaborations
Marco collaborates with Theodorus Jansen, who is also involved in the research and development of vaccine formulations. Their combined efforts aim to enhance the stability and efficacy of vaccines, benefiting public health initiatives.
Conclusion
Marco Groot's innovative work in the field of vaccine emulsification has the potential to significantly impact vaccine stability and effectiveness. His contributions are vital for the advancement of immunological research and public health.